Article: | MedLuna.com

Overview

Journal CMAJ

Date 2020 Dec 15

PMID 33318097

Authors

Lucas C Godoy

Ewan C Goligher

Patrick R Lawler

Arthur S Slutsky

Ryan Zarychanski

Affiliations

Soon will be listed here.

References

Paranjpe I, Fuster V, Lala A, Russak A, Glicksberg B, Levin M . Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. J Am Coll Cardiol. 2020; 76(1):122-124. PMC: 7202841. DOI: 10.1016/j.jacc.2020.05.001. View

Thachil J . The versatile heparin in COVID-19. J Thromb Haemost. 2020; 18(5):1020-1022. PMC: 9906146. DOI: 10.1111/jth.14821. View

Batlle D, Soler M, Sparks M, Hiremath S, South A, Welling P . Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. J Am Soc Nephrol. 2020; 31(7):1380-1383. PMC: 7350999. DOI: 10.1681/ASN.2020040419. View

Bhayana R, Som A, Li M, Carey D, Anderson M, Blake M . Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology. 2020; 297(1):E207-E215. PMC: 7508000. DOI: 10.1148/radiol.2020201908. View

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

Cao W, Li T . COVID-19: towards understanding of pathogenesis. Cell Res. 2020; 30(5):367-369. PMC: 7186532. DOI: 10.1038/s41422-020-0327-4. View

Dilsizian V, Arrighi J, Cohen R, Miller T, Solomon A, Udelson J . COCATS 4 Task Force 6: Training in Nuclear Cardiology. J Am Coll Cardiol. 2015; 65(17):1800-9. DOI: 10.1016/j.jacc.2015.03.019. View

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-147. PMC: 7146714. DOI: 10.1016/j.thromres.2020.04.013. View

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

10.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

11.

Morici N, Bottiroli M, Fumagalli R, Marini C, Cattaneo M . Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink. Thromb Haemost. 2020; 120(9):1339-1342. DOI: 10.1055/s-0040-1713400. View

12.

Schunemann H, Cushman M, Burnett A, Kahn S, Beyer-Westendorf J, Spencer F . American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018; 2(22):3198-3225. PMC: 6258910. DOI: 10.1182/bloodadvances.2018022954. View

13.

Shi S, Qin M, Cai Y, Liu T, Shen B, Yang F . Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020; 41(22):2070-2079. PMC: 7239100. DOI: 10.1093/eurheartj/ehaa408. View

14.

Zhou X, Li Y, Yang Q . Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19: Implications From Clinical Features to Pathologic Findings. Circulation. 2020; 141(22):1736-1738. DOI: 10.1161/CIRCULATIONAHA.120.046988. View

15.

Bikdeli B, Madhavan M, Gupta A, Jimenez D, Burton J, Nigoghossian C . Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020; 120(7):1004-1024. PMC: 7516364. DOI: 10.1055/s-0040-1713152. View

16.

Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart D . Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med. 2020; 383(3):288-290. PMC: 7217555. DOI: 10.1056/NEJMc2013656. View

17.

Lee S, Fralick M, Sholzberg M . Coagulopathy associated with COVID-19. CMAJ. 2020; 192(21):E583. PMC: 7259970. DOI: 10.1503/cmaj.200685. View

18.

Noris M, Benigni A, Remuzzi G . The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020; 98(2):314-322. PMC: 7246017. DOI: 10.1016/j.kint.2020.05.013. View

19.

Levi M, Scully M, Singer M . The role of ADAMTS-13 in the coagulopathy of sepsis. J Thromb Haemost. 2018; 16(4):646-651. DOI: 10.1111/jth.13953. View

20.

Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X . Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020; 50(3):548-557. PMC: 7286212. DOI: 10.1007/s11239-020-02171-y. View